March 25, 2022 – StemWave introduces new partnership as the exclusive distributor for North America with global shockwave manufacturer Inceler Medikal. Inceler Medikal is a world-leading shockwave manufacturer and researcher based in Turkey, who has eagerly seeked market access to North America. The StemWave executive team has years of experience in commercialization of shock-wave products and plans to make Incelers products market leaders in North America.
StemWave & Inceler will start by introducing Modus, a focused shockwave device that has been re-engineered for orthopedic application. Modus is one of the only electro-hydraulic shock wave devices available in the US.
Focused shockwave devices have shown up to 90% success rates with various chronic musculoskeletal indications. As a state of the art device, Modus plans to achieve similar outcomes with its newly introduced technology.
StemWave will begin distribution to the orthopedic sector on April 1st, 2022.
StemWave is committed to rehabilitation accessible to the world by developing revolutionary technology that reshapes traditional healthcare.